News

Dermagnostix CEO and Co-founder Prof. Dr. Natalie Garzorz Stark has been awared the Innovation Award Dermatology by Bundesverband der Deutschen Dermatologen (BVDD) e.V. The BVDD Innovation Award is an annual competition honoring innovative approaches that enhance dermatological practice and patient care. Recognized projects include innovative patient care models, advancements in dermatological prevention, new diagnostic and […]

The President of the Baden-Württemberg Parliament, Muhterem Aras, and Nadyne Saint-Cast, Member of Parliament, recently visited Dermagnostix at its offices in the Biotech-Park Freiburg. They were welcomed by CEO Prof. Dr. Natalie Garzorz-Stark and CTO Ludwig Gutzweiler, who provided insights into the company’s history and development.  Discussions focused on the specific challenges and opportunities for […]

We are excited to announce the launch of our new webinar series “Beyond the Surface: Revolutionizing Skin Diagnostics Through Molecular Science”. These sessions bring together leading scientists, clinicians, and industry experts to explore cutting-edge discoveries that are transforming diagnostics and enhancing patient care. Prof. Dr. Kilian Eyerich kicks off the series with the first on-demand […]

Dermagnostix has been selected by the EIC- International Fairs 3.0 Programme as a startup with groundbreaking innovation for MEDICA 2024 (11.-14. November in Düsseldorf, Germany). With this selection, EIC enables Dermagnostix to participate at MEDICA with a booth in the EIC/EU Pavilion and to present our innovative molecular diagnostic solution for dermatology. The EIC International Trade […]

June was packed with exciting events and we had a great time exhibiting at ADH annual meeting in Göttingen as well as IFPA conference in Stockholm. The 31st annual meeting of the “Arbeitsgemeinschaft Dermatologische Histologie” (ADH) took place under the motto future perspectives of dermatopathology including the requirements for molecular dermatopathology. We took the opportunity to […]

Dermagnostix announces the official launch of the PsorX®-LabDisk. After the market entry with CE-IVD certification in 2022 and a following successful pilot customer phase, the innovative molecular test for the differential diagnosis of psoriasis and eczema was officially launched in June 2024. The Dermagnostix system consisting of the LabDisk-Analyzer, LabDisk and the Connectivity Solution marks […]